-
The difficult problems faced by medical reform need to be solved by the introduction of health law
Time of Update: 2021-02-05
addition, the formulation of the Basic Law on Health can no longer be considered within the existing terms of reference of the Health and Family Planning Administration, and the overall health work should be used to grasp the relationship between government departments and other types of social relations.
-
The General Administration of Food and Drug Administration issues an announcement on the filing of clinical trials of medical devices
Time of Update: 2021-02-02
the Announcement, the bidders shall submit relevant materials for clinical trials of medical devices, file a record with the provincial food and drug regulatory department in the locality, and import medical devices with the provincial food and drug supervision and administration department where the agent is located.
-
A new mechanism of tumor immune escape has been discovered
Time of Update: 2021-01-04
CD8-T is a T lymphocyte with lethal function, which play a central role in tumor immunity, and how to activate such cells is the focus of research in this field.
-
China's petroleum polyolefin new products major scientific and technological special through acceptance
Time of Update: 2020-12-21
July 19, at a special acceptance assessment meeting in early July, PetroChina's "Polyolefin New Product Research and Development and Industrial Applications" major science and technology special proj
-
Quickly and sensitively identify multidrive bacteria
Time of Update: 2020-12-11
In addition, RNA molecules can be used to detect resistant genes in bacterial genetic material.
The system allows them to detect RNA from a single antibiotic-resistant bacteria without having to enlarge or label the sample for analysis.
-
BMS Opdivo and Yervoy first-line treatment of malignant thoracic intersessives
Time of Update: 2020-11-30
On November 23rd, the website of the Drug Review Center (CDE) of the State Drug Administration of China announced that the PD-1 inhibitor Navuliyu monoanti and CTLA-4 antibody Ipimu monoantigen combination therapy with "conditionally approved drugs" would be included in the priority review, and that the adaptation should be developed as: for the treatment of non-removable non-epithelial malignant mammalinoma patients for primary treatment.
-
CytoSys: A Tool for Extracting Cell-Cycle-Related Expression Dynamics from Static Data
Time of Update: 2020-11-29
We demonstrate the use of CytoSys with a case study of exponentially growing, human erythroleukemia cells and extract the dynamic expression profiles of cyclin A for calibrating an existing deterministic mathematical model of the cell cycle.
-
Fire-resistant paint: "Prevent the spread of fire
Time of Update: 2020-11-13
These coatings work through foaming and form protective foams in the event of a fire, providing excellent high temperature insulation.
Ammonium polyphosphate also forms a carbon layer on the surface and reacts with the coating composition, protecting building materials from oxygen supply and preventing further spread of flame.
-
Selection of wetting and dispersing agents for dispersing organic pigments and carbon black
Time of Update: 2020-10-26
Generally speaking, compared with inorganic pigments, organic pigments have small particle size, longer than the surface, low polar characteristics, and carbon black although from a chemical point of view is inorganic, but from the point of view of the coating industry, it is very similar to the use of organic pigments, so when selecting dispersants, these two pigments can usually use the same dispersant additives.
-
Pay attention to intellectual property rights, regulate enterprise management! Pharmaceutical intelligence network held an intellectual property standard launch meeting
Time of Update: 2020-09-05
Photo and this time, pharmaceutical intellectual property management norms (GB/T29490-2013) through the bid launch meeting, in order to promote the standardization of the enterprise intellectual property management system, the purpose of which is mainly to highlight the management of intellectual property rights, protect their rights and interests, while building the core competitiveness of enterprises.
-
The DNA shear active structure of CRISPR-Cas9 was analyzed by using the three-dimensional reconstruction method of cryptoscope single particles
Time of Update: 2020-08-20
Today, the research results of the gene editing system CRISPR-Cas9, conducted online by Huang Qiang Of fudan University's School of Life Sciences and the National Key Laboratory of Genetic Engineering, in collaboration with The Lu Daju Group, were published online in the internationally renowned academic journal Nature Communications.
-
Chinese veterinary medicine will become the main force of resistance
Time of Update: 2020-08-01
x4E the comparison of the three alternative anti-resistance schemes x4E what to replace antibiotics, each practitioner has its own thinking, but there is a basic consensus, one is acidifier, one is vegetable essential oils, spices, and is to use a high concentration of metal ions, such as zinc oxide.
-
Arthritis pain "death to live", these methods are too useful! Guide time
Time of Update: 2020-07-28
the guidelines for non-surgical treatment of osteoarthritis published by OARSI in 2019 strongly recommend topical NSAIDs for patients with knee OA, especially for patients with gastrointestinal and / or cardiovascular diseases, as well as elderly and frail patients.
-
"Big flip" or "an empty"? New preparation plus holding, Gilead multi-directional exploration
Time of Update: 2020-07-20
Guide: New dosage forms, combination medications, and more, Gilead reveals several research trends in Redsiwe reedsewe for nearly two days, news, yesterday, India's generic drug has just been approved, today Gilead announced a clinical trial of Redsiweinative inhaling agents, with the intention of early intervention to avoid hospitalization of patients, and Gilead also revealed its exploration of many directions ..
-
Nature Medcine: The first CD70 mono-antitherapy for acute leukemia was effective, with 67% of patients completely remission
Time of Update: 2020-07-18
Cusatuzumab can produce a variety of anticancer effects by binding with CD70, including blocking cd70-cd27 signal transduction, inhibiting the proliferation of leukemic stem cells, antibody dependent cytotoxicity, complement dependent cytotoxic effect and killing Death of CD70 expressing cancer cells, stimulation of tumor cell differentiation and death, and remodeling of immune system to monitor solid tumors.
